Ensayo clínico para evaluar la respuesta después de cirugía de metastásis hepáticas en cáncer colorrectal en tratamiento con bevacizumab y XELOX.
Ontology highlight
ABSTRACT: Primary objectives: Correlation between global objectives response according RECIST v1.1 criteria evaluated by conventional images tecniques with morfologic response by TAC and pathologic response after hepatic metastatic resectability.
Primary endpoints: Objectives response rate according RECIST v1.1 criteria. Morfologic response rate by TCMD. Pathologic response rate after hepatic metastatic resectability.
DISEASE(S): Patients With Resectable Hepatic Metastasis Secundary To Colorectal Cancer,Pacientes Con Metástasis Hepáticas Resecables Secundarias A Cáncer Colorrectal.,Metastatic Colon Cancer,Patients With Resectable Hepatic Metastasis Secundary To Colorectal Cancer
PROVIDER: 2529162 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA